We are live on ! Find out more

553 hedge funds and large institutions have $8.5B invested in Chemed in 2025 Q1 according to their latest regulatory filings, with 86 funds opening new positions, 184 increasing their positions, 198 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

62% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 53

57% more call options, than puts

Call options by funds: $8.12M | Put options by funds: $5.16M

16% more capital invested

Capital invested by funds: $7.35B → $8.5B (+$1.14B)

5% more funds holding

Funds holding: 528553 (+25)

1.67% more ownership

Funds ownership: 92.67%94.35% (+1.7%)

7% less repeat investments, than reductions

Existing positions increased: 184 | Existing positions reduced: 198

Holders
553
Holders Change
+25
Holders Change %
+4.73%
% of All Funds
7.41%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.07%
New
86
Increased
184
Reduced
198
Closed
53
Calls
$8.12M
Puts
$5.16M
Net Calls
+$2.96M
Net Calls Change
-$7.96M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.01B -$16.2M -28,554 -2%
BlackRock
2
BlackRock
New York
$850M -$640K -1,126 -0.1%
Kayne Anderson Rudnick Investment Management
3
Kayne Anderson Rudnick Investment Management
California
$367M +$8.55M +15,041 +3%
Neuberger Berman Group
4
Neuberger Berman Group
New York
$321M +$11.2M +19,650 +4%
State Street
5
State Street
Massachusetts
$298M +$2.63M +4,625 +1%
William Blair Investment Management
6
William Blair Investment Management
Illinois
$272M -$18.2M -31,973 -7%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$219M +$8.85M +15,574 +5%
Morgan Stanley
8
Morgan Stanley
New York
$193M +$3.17M +5,581 +2%
Impax Asset Management Group
9
Impax Asset Management Group
United Kingdom
$186M -$17.6M -30,877 -9%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$167M -$7.19M -12,645 -4%
TD Asset Management
11
TD Asset Management
Ontario, Canada
$163M -$3.84M -6,750 -2%
EIP
12
Epoch Investment Partners
New York
$154M -$867K -1,526 -0.6%
BTW
13
Boston Trust Walden
Massachusetts
$152M +$2.38M +4,179 +2%
JP Morgan Chase
14
JP Morgan Chase
New York
$151M -$11.7M -20,671 -8%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$135M +$11M +19,421 +10%
Northern Trust
16
Northern Trust
Illinois
$133M +$3.97M +6,988 +3%
Norges Bank
17
Norges Bank
Norway
$124M +$11.2M +19,792 +11%
Invesco
18
Invesco
Georgia
$111M -$997K -1,754 -1%
Ameriprise
19
Ameriprise
Minnesota
$104M -$36.7M -64,655 -28%
DekaBank Deutsche Girozentrale
20
DekaBank Deutsche Girozentrale
Germany
$92.7M -$391K -688 -0.4%
CCM
21
Copeland Capital Management
Pennsylvania
$91.7M -$1.47M -2,588 -2%
Charles Schwab
22
Charles Schwab
California
$91.6M +$7.24M +12,738 +9%
Acadian Asset Management
23
Acadian Asset Management
Massachusetts
$91.1M -$3.85M -6,779 -4%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$89.9M +$2.15M +3,782 +3%
Fuller & Thaler Asset Management
25
Fuller & Thaler Asset Management
California
$80M +$52.8M +92,813 +249%

CHE Hedge Fund Activity: Q1 2025 in Review

553 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q1 2025, worth a combined $8.5B — up 16% from $7.35B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new CHE positions and 53 closed out — a net gain of 33 holders — while 184 added to existing stakes and 198 trimmed.

The largest buyer was Fuller & Thaler Asset Management, adding an estimated $52.8M. The largest seller was Freestone Grove Partners, exiting entirely with an estimated $61.7M sold.

  • 553 institutional investors held Chemed (CHE) as of Q1 2025, up from 528 in Q4 2024.
  • Funds reported $8.5B of Chemed stock for Q1 2025, up 16% quarter-over-quarter.
  • 86 funds opened new Chemed positions in Q1 2025 and 53 closed out, a net change of +33 holders.
  • The largest Chemed buyer in Q1 2025 was Fuller & Thaler Asset Management, an estimated $52.8M added.
  • The largest Chemed seller in Q1 2025 was Freestone Grove Partners, an estimated $61.7M sold.

Based on aggregated 13F filings for Q1 2025.